Genmab A/S Files 6-K, Incorporates Updates into S-8 Filings
Ticker: GNMSF · Form: 6-K · Filed: Nov 26, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Nov 26, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, corporate-update, registration-statement
TL;DR
Genmab 6-K filed Nov 26, 2025 - updates incorporated into S-8s. Articles of Association included.
AI Summary
Genmab A/S filed a Form 6-K on November 26, 2025, to report updates. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876. The report includes their Articles of Association as Exhibit 3.1.
Why It Matters
This filing ensures that Genmab's ongoing registration statements for its equity incentive plans are kept up-to-date with its latest corporate information, maintaining compliance.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer to update incorporated documents and does not appear to contain material new financial or operational information.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
- 333-284876 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The purpose of this Form 6-K filing is to report updates and to be incorporated by reference into Genmab A/S's existing registration statements on Form S-8.
On what date was this Form 6-K filed?
This Form 6-K was filed on November 26, 2025.
Which specific registration statements will this filing be incorporated into?
This filing will be incorporated into Genmab A/S's registration statements on Form S-8 with File Numbers 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What document is included as an exhibit in this filing?
The Articles of Association of Genmab A/S are included as Exhibit 3.1 in this filing.
What is the principal executive office address for Genmab A/S?
The principal executive office address for Genmab A/S is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Stats: 211 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2025-11-26 07:04:22
Filing Documents
- gmab_20251126x6k.htm (6-K) — 13KB
- gmab_20251126xex3d1.htm (EX-3.1) — 237KB
- 0001434265-25-000104.txt ( ) — 250KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF NOVEMBER 2025 COMMISSION FILE NUMBER 001-38976 Genmab AS (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab AS's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit Description of Exhibit 3.1 Articles of Association SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB AS BY s Anthony Pagano Name Anthony Pagano Title Executive Vice President Chief Financial Officer DATE November 26, 2025